Associate Professor Michael Kennedy is a Consultant Physician and Clinical Pharmacologist. MB BS (Syd) FRACP and MD from University of NSW in pharmacology. Clinical experience includes an acute metropolitan hospital general roster for over 30 years and private practice in the same area. Pharmaceutical industry experience with Searle International, both locally and overseas, in collaboration with it’s UK and USA-based facilities covering a wide variety of agents. Phase 1 research on antiarrhythmics was undertaken locally in the St Vincent’s Hospital Department of Clinical Pharmacology.
Other research activities include: drugs in sport, sporting trauma, adverse drug reactions, medical ethics and ethical aspects of clinical trials, end of life decisions and forensic pharmacology.
Society activities have included a membership of a number of Royal Australasian College of Physicians (RACP ) training programmes, as well as numerous other committees, major involvement in the establishment and progress of the Internal Medicine Society of Australia and New Zealand (IMSANZ) and Foundation member of the Forensic and Clinical Toxicology Association (FACTA).

Associate Professor Kennedy's present interest in cannabis relates to its use in sport, clinical application and forensic toxicology.